BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 11:43:00 AM | Browse: 976 | Download: 753
Publication Name World Journal of Gastroenterology
Manuscript ID 8004
Country Italy
Received
2013-12-11 09:48
Peer-Review Started
2013-12-11 17:48
To Make the First Decision
2014-01-15 13:37
Return for Revision
2014-01-20 18:30
Revised
2014-02-07 22:19
Second Decision
2014-03-10 15:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-10 16:54
Articles in Press
2014-05-23 10:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-22 16:27
Publish the Manuscript Online
2014-07-03 15:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival
Manuscript Source Unsolicited Manuscript
All Author List Marco Biolato, Luca Miele, Vittoria Vero, Simona Racco, Carmine Di Stasi, Roberto Iezzi, Andrea Zanché, Maurizio Pompili, Gian Ludovico Rapaccini, Giuseppe La Torre, Antonio Gasbarrini and Antonio Grieco
Funding Agency and Grant Number
Corresponding Author Antonio Grieco, MD, Professor of Medicine, Hepatology Unit, Department of Internal Medicine, Policlinico Gemelli Hospital and Catholic University of the Sacred Heart, Largo Agostino Gemelli n 8, 00168 Rome, Italy. agrieco@rm.unicatt.it
Key Words Liver cancer; Sorafenib; Hyponatremia; Model for end-stage liver disease sodium; Chemoembolization
Core Tip This work describes, in a retrospective cohort of 270 patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (TACE) at our institution, the prognostic role of baseline clinical, biochemical and radiological characteristics of patients. Besides well-known prognostic parameters like portal vein thrombosis, nodule diameter and number of lesions, this study underlines the independent prognostic role of serum sodium, a well-known prognostic parameter in the field of liver cirrhosis, but less investigated in the field of hepatocellular carcinoma. Our study is the first to document the prognostic role of serum sodium in patients with HCC treated with TACE in a Western center.
Publish Date 2014-07-03 15:30
Citation Biolato M, Miele L, Vero V, Racco S, Di Stasi C, Iezzi R, Zanché A, Pompili M, Rapaccini GL, La Torre G, Gasbarrini A, Grieco A. Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival. World J Gastroenterol 2014; 20(25): 8158-8165
URL http://www.wjgnet.com/1007-9327/full/v20/i25/8158.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i25.8158
Full Article (PDF) WJG-20-8158.pdf
Full Article (Word) WJG-20-8158.doc
Manuscript File 8004-Review.doc
Answering Reviewers 8004-Answering reviewers.pdf
Copyright License Agreement 8004-Copyright_Assignment.pdf
Non-Native Speakers of English Editing Certificate 8004-Language certificate.pdf
Peer-review Report 8004-Peer review(s).pdf
Scientific Editor Work List 8004-Scientific editor work list.doc